NCT01949675View on ClinicalTrials.gov

A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines

PHASE4CompletedINTERVENTIONAL
Enrollment

336

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

August 31, 2015

Conditions
Cholera
Interventions
BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

BIOLOGICAL

Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell

1.5 mL, Oral administration

Trial Locations (2)

Unknown

City of Muntinlupa

Manila

All Listed Sponsors
lead

Sanofi Pasteur, a Sanofi Company

INDUSTRY

NCT01949675 - A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines | Biotech Hunter | Biotech Hunter